Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intraethnic variation in steroid-5-alpha-reductase polymorphismsin prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment.

Journal of genetics - 1 Jun 2015

Henríquez-Hernández Luis Alberto, Valenciano Almudena, Foro-Arnalot Palmira, Álvarez-Cubero María Jesús, Cozar José Manuel, Suárez-Novo José Francisco, Castells-Esteve Manel, Fernández-Gonzalo Pablo, De-Paula-Carranza Belén, Ferrer Montse, Guedea Ferrán, Sancho-Pardo Gemma, Craven-Bartle Jordi, Ortiz-Gordillo María José, Cabrera-Roldán Patricia, Herrera-Ramos Estefanía, Rodríguez-Gallego Carlos, Lara Pedro C

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Share to Ethnicity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Share to Principal Component Analysis

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 26174685
DOI: 10.1007/s12041-015-0511-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intraethnic variation in steroid-5-alpha-reductase polymorphismsin prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment.PMID 26174685Read ↗

Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer.Semantic proximity Read ↗

Prostatic steroid 5 alpha-reductase, an androgen metabolic gene.Semantic proximity Read ↗

Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.Semantic proximity Read ↗

Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.Semantic proximity Read ↗

Editorial comment on: Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.Semantic proximity Read ↗

Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.Semantic proximity Read ↗

Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.Semantic proximity Read ↗

Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk. Mutations in brief no. 191. Online.Semantic proximity Read ↗

TA repeat polymorphism of the 5alpha-reductase gene and breast cancer.Semantic proximity Read ↗

Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse.Semantic proximity Read ↗

Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1.Semantic proximity Read ↗

Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.